Fitterfly, a Navi Mumbai-based health tech start-up specialising in Digital Therapeutics (DTx) and is founded and run by a team of Doctors, Engineers and Senior Nutritionists, has raised $3.1 million in a Pre-Series A funding round led led by Fireside Ventures.
9Unicorns — the accelerator fund of Venture Catalysts —Venture Catalysts and a clutch of angel investors from India, the US and Singapore, also participated in the current round.
Funds will be used for improving the solution to deliver better patient outcomes at scale and impacting a large number of people by creating better awareness and reach. In June 2019, Fitterfly had raised a seed round of $1 million from HNIs, family and friends.
Kanwaljit Singh, Managing Partner at Fireside Ventures, also joins as a board member.
“Four years ago, we started building India’s largest clinical nutrition database and then validated it by building disease-specific nutrition advisory algorithms. From there we pivoted to DTx in late 2019 recognising the large unmet need for remote support in improving outcomes. Covid-19 has pushed remote monitoring and digital therapeutics to the forefront of medicine. We are solving difficult problems that affect almost 30-40 per cent of the population. We are seeing good support from doctors as a prescription product, saving their time and helping them achieve better outcomes,” said Dr Arbinder Singal, co-founder and CEO, Fitterfly.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.